View Item 

Show simple item record

Phase II Trial of Docetaxel Chemotherapy in Patients with Incurable Adenocarcinoma of the Esophagus
dc.contributor.authorHeath, Elisabeth I.en_US
dc.contributor.authorUrba, Susan G.en_US
dc.contributor.authorMarshall, Johnen_US
dc.contributor.authorPiantadosi, Stevenen_US
dc.contributor.authorForastiere, Arlene A.en_US
dc.date.accessioned2006-09-11T15:48:00Z
dc.date.available2006-09-11T15:48:00Z
dc.date.issued2002-02en_US
dc.identifier.citationHeath, Elisabeth I.; Urba, Susan; Marshall, John; Piantadosi, Steven; Forastiere, Arlene A.; (2002). "Phase II Trial of Docetaxel Chemotherapy in Patients with Incurable Adenocarcinoma of the Esophagus." Investigational New Drugs 20(1): 95-99. <http://hdl.handle.net/2027.42/45210>en_US
dc.identifier.issn0167-6997en_US
dc.identifier.issn1573-0646en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/45210
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12003198&dopt=citationen_US
dc.description.abstractBackground : Chemotherapy remains theprimary mode of treatment for metastaticcarcinoma of the esophagus. The efficacyof various chemotherapeutic regimens hasbeen studied predominantly in patients withsquamous cell carcinoma of the esophagus. In light of the increasing incidence ofadenocarcinoma of the esophagus, studiesevaluating newer chemotherapy agents, suchas docetaxel, in this patient populationare necessary. The objective of this trialwas to determine the complete and partialresponse rate of docetaxel in patients withincurable adenocarcinoma of theesophagus.en_US
dc.format.extent59249 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers; Springer Science+Business Mediaen_US
dc.subject.otherMedicine & Public Healthen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherOncologyen_US
dc.subject.otherCancer of the Esophagusen_US
dc.subject.otherChemotherapyen_US
dc.subject.otherDocetaxelen_US
dc.subject.otherPaclitaxelen_US
dc.titlePhase II Trial of Docetaxel Chemotherapy in Patients with Incurable Adenocarcinoma of the Esophagusen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelRadiologyen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbsecondlevelChemical Engineeringen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelEngineeringen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Oncology, University of Michigan, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MP, USAen_US
dc.contributor.affiliationotherDepartment of Oncology, Georgetown University Hospital, Washington, DC, USAen_US
dc.contributor.affiliationotherDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MP, USAen_US
dc.contributor.affiliationotherDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MP, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid12003198en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/45210/1/10637_2004_Article_390685.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1014476602804en_US
dc.identifier.sourceInvestigational New Drugsen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
10637_2004_Article_390685.pdf
Size:
57.86KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.